openPR Logo
Press release

Poly Adenosine Diphosphate Ribose Polymerase Market Drivers

08-24-2018 04:05 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Poly Adenosine Diphosphate Ribose Polymerase Market Drivers

Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair of single stranded breaks in DNA that effectively destroys cancer cells.

These inhibitors play an effective role in current cancer-combating strategies, owing to its effectiveness in eliminating cancer cells as compared to the existing ovarian cancer treatments. Drugs such as Talazoparib and Veliparib that aid in treatment of ovarian cancer are in phase III clinical trials. Such research and development activities is a key factor contributing to the global poly adenosine diphosphate ribose polymerase market growth.

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/2029

High prevalence of various types of cancer is a key factor contributing to growth of the global poly adenosine diphosphate ribose polymerase market. Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. According to American Cancer Society (ASC), around 22,240 women are expected to be diagnosed with ovarian cancer, and around 14,070 deaths are expected from the disease in 2018.

Furthermore, introduction of new drugs has propelled the poly adenosine diphosphate ribose polymerase market growth. For instance, the U.S. Food & Drug Administration approved 3 PARP inhibitors—Olaparib, Rucaparib, and Niraparib. These drugs are a potential alternative that aid in treatment of ovarian and other cancers after paclitaxel.

Moreover, combination of these PARP inhibitors with other therapies such as monoclonal antibodies is under research. For instance, in May 2018, TESARO, Inc.—an oncology-focused biopharmaceutical company— announced collaboration with Genentech—a member of the Roche Group—to evaluate the combination of the PD-L1 antibody— Atezolizumab (TECENTRIQ), the MEK inhibitor cobimetinib (COTELLIC), and TESARO’s PARP inhibitor ZEJULA (Niraparib) — in patients with platinum-sensitive ovarian cancer. In April 6, 2018, the U.S. Food and Drug Administration (FDA) approved Rubraca (rucaparib) tablets --manufactured by Clovis Oncology Inc.—for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients.

Moreover, robust pipeline of poly adenosine diphosphate ribose polymerase inhibitors is major factor contributing to the market growth over the forecast period. For instance, AbbVie’s and Pfizer Inc. have Veliparib and Talazoparib – in phase 3 clinical trials. Furthermore, these drugs are expected to be effective in the treatment of diseases other than ovarian cancer and the research for expanding indications is underway as well. For instance, Talazoparib developed by Pfizer Inc., is in phase 3 clinical trials for treatment of prostate cancer.

Download The PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2029

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Poly Adenosine Diphosphate Ribose Polymerase Market Drivers here

News-ID: 1200763 • Views:

More Releases from Coherent Market Insights

Colon And Rectal Cancer Drugs Market Empowering Treatment: Dynamic Trends in 2024-2031 |  Amgen Inc., AstraZeneca plc, Bayer AG, Boehringer Ingelheim
Colon And Rectal Cancer Drugs Market Empowering Treatment: Dynamic Trends in 202 …
The "Colon And Rectal Cancer Drugs Market was valued for $6.5 billion in 2024 and is estimated to reach $18.5 billion by 2031, exhibiting a CAGR of 11.2% from 2024 to 2031. Coherent Market Insights has released a statistical report titled "Colon And Rectal Cancer Drugs Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and
Foot And Mouth Disease Vaccine Market Exploring Distinctive Approaches in the 2024-2031 | Agrovet, Indian Immunologicals Ltd., MSD Animal Health
Foot And Mouth Disease Vaccine Market Exploring Distinctive Approaches in the 20 …
The "Foot And Mouth Disease Vaccine Market was valued for $6.5 billion in 2024 and is estimated to reach $18.5 billion by 2031, exhibiting a CAGR of 11.2% from 2024 to 2031. Coherent Market Insights has released a statistical report titled "Foot And Mouth Disease Vaccine Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and
Pemirolast Market 2031 provides an in-depth insight of Sales and Trends Forecast to 2031
Pemirolast Market 2031 provides an in-depth insight of Sales and Trends Forecast …
Report Summary: Coherent Industry Insights presents encyclopedic research of the Pemirolast Market with holistic insights into significant variables and features driving the future growth of the market. The Pemirolast Market was studied for the projected year 2023-2030 as well as the historical period 2017-2022. The research study provides complete qualitative and quantitative analysis to help shareholders obtain a thorough grasp of the Pemirolast Market and its crucial dynamics. In accordance with coherent
Congestive Heart Failure Drugs Market Beyond the Beat: Exploring Distinctive Avenues in Overall Study Report 2024-2031 | Amgen Inc, Novartis AG, Astra Zeneca Plc
Congestive Heart Failure Drugs Market Beyond the Beat: Exploring Distinctive Ave …
The "Congestive Heart Failure Drugs Market was valued for $6.5 billion in 2024 and is estimated to reach $18.5 billion by 2031, exhibiting a CAGR of 11.2% from 2024 to 2031. Coherent Market Insights has released a statistical report titled "Congestive Heart Failure Drugs Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation

All 5 Releases


More Releases for Poly

Poly-Vents Market to Witness Remarkable Growth | Filtration Group Corporation; P …
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Poly-Vents Market Analysis and Forecast, 2020 – 2027”. In this report, Researchers have analysed Strength, Weakness, opportunities and threats in the market and provides the unbiased picture of the market with the informative knowledge. The Poly-Vents Market report additionally states import/trade utilization, free market activity figures, cost, value, volume and gross edges. The study bridges the historical
Poly-Vents Market To Witness Astonishing Growth | Competitive Outlook By Filtrat …
The Latest survey report on Poly-Vents Market?research gives a holistic overview of the growth and other aspects of the industry in vital countries (regions). The regions provided in this market document show the geographical boundaries across the globe. This report is a wonderful guide to achieve an information or key data about market, emerging trends, product usage, customer inclinations, motivating factors for customers, competitor strategies, brand positioning, future trends, customer
Poly Adenosine Diphosphate Ribose Polymerase Market Drivers
Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair
Poly Hydroxyalkanoate Market Analysis Report
The global Poly Hydroxyalkanoate market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Detailed Report With TOC: https://www.reportsandmarkets.com/reports/global-and-japan-poly-hydroxyalkanoate-market-analysis-report-1532782 Japan plays an important role in the global market, with the market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of
Poly Hydroxyalkanoate Market Research Report 2017-2022
The global Poly hydroxyalkanoate market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Detailed Report With TOC Here: https://www.reportsandmarkets.com/reports/global-poly-hydroxyalkanoate-market-research-report-types-applications-1532600 This report offers an overview of the market trends, drivers, and barriers with respect to the Polyhydroxyalkanoate market. It also provides a detailed overview of the market of different regions
Global Alcohol Poly Ethoxylates To boost industry
Alcohol Poly Ethoxylates Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Alcohol Poly Ethoxylates basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes;